| Report Title | Price | Action |
|---|---|---|
| Rift Valley Fever (Infectious Disease) - Drugs in Development, 2021
Rift Valley Fever (Infectious Disease) - Drugs in Development, 2021 Summary Rift Valley Fever (Infectious Disease) - Drugs in Development, 2021 prov...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Interferon Alpha/Beta Receptor 2 (Interferon Alpha Binding Protein or Type I Interferon Receptor 2 or IFNAR2) - Drugs in Development, 2021
Interferon Alpha/Beta Receptor 2 (Interferon Alpha Binding Protein or Type I Interferon Receptor 2 or IFNAR2) - Drugs in Development, 2021 Summary I...
Published: Apr-2021 | No. of Pages: 85
|
$ 3000 | |
| Platelet Derived Growth Factor Receptor Beta (Beta Type Platelet Derived Growth Factor Receptor or CD140 Antigen Like Family Member B or Platelet Derived Growth Factor Receptor 1 or CD140b or PDGFRB or EC 2.7.10.1) - Drugs in Development, 2021
Platelet Derived Growth Factor Receptor Beta (Beta Type Platelet Derived Growth Factor Receptor or CD140 Antigen Like Family Member B or Platelet Deri...
Published: Apr-2021 | No. of Pages: 75
|
$ 3000 | |
| Protein Tyrosine Phosphatase (EC 3.1.3.48) - Drugs in Development, 2021
Protein Tyrosine Phosphatase (EC 3.1.3.48) - Drugs in Development, 2021 Summary Protein Tyrosine Phosphatase (EC 3.1.3.48) - Drugs in Development, 2...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Fungal Infections (Infectious Disease) - Drugs in Development, 2021
Fungal Infections (Infectious Disease) - Drugs in Development, 2021 Summary Fungal Infections (Infectious Disease) - Drugs in Development, 2021 prov...
Published: Apr-2021 | No. of Pages: 130
|
$ 2000 | |
| Salmonella typhimurium Infections (Infectious Disease) - Drugs in Development, 2021
Salmonella typhimurium Infections (Infectious Disease) - Drugs in Development, 2021 Summary Salmonella typhimurium Infections (Infectious Disease) -...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Adenosine Receptor A2a (ADORA2A) - Drugs in Development, 2021
Adenosine Receptor A2a (ADORA2A) - Drugs in Development, 2021 Summary Adenosine Receptor A2a (ADORA2A) - Drugs in Development, 2021 provides in dept...
Published: Apr-2021 | No. of Pages: 90
|
$ 3000 | |
| Toll Like Receptor 9 (CD289 or TLR9) - Drugs in Development, 2021
Toll Like Receptor 9 (CD289 or TLR9) - Drugs in Development, 2021 Summary Toll Like Receptor 9 (CD289 or TLR9) - Drugs in Development, 2021 provides...
Published: Apr-2021 | No. of Pages: 75
|
$ 3000 | |
| Rhodopsin (Opsin 2 or OPN2 or RHO) - Drugs in Development, 2021
Rhodopsin (Opsin 2 or OPN2 or RHO) - Drugs in Development, 2021 Summary Rhodopsin (Opsin 2 or OPN2 or RHO) - Drugs in Development, 2021 provides in ...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Primary Mediastinal B-Cell Lymphoma (Oncology) - Drugs in Development, 2021
Primary Mediastinal B-Cell Lymphoma (Oncology) - Drugs in Development, 2021 Summary Primary Mediastinal B-Cell Lymphoma (Oncology) - Drugs in Develo...
Published: Apr-2021 | No. of Pages: 130
|
$ 2000 | |
| Skin And Skin Structure Infections (SSSI) (Infectious Disease) - Drugs in Development, 2021
Skin And Skin Structure Infections (SSSI) (Infectious Disease) - Drugs in Development, 2021 Summary Skin And Skin Structure Infections (SSSI) (Infec...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Proto Oncogene Tyrosine Protein Kinase Receptor Ret (Cadherin Family Member 12 or Proto Oncogene c Ret or RET or EC 2.7.10.1) - Drugs in Development, 2021
Proto Oncogene Tyrosine Protein Kinase Receptor Ret (Cadherin Family Member 12 or Proto Oncogene c Ret or RET or EC 2.7.10.1) - Drugs in Development, ...
Published: Apr-2021 | No. of Pages: 90
|
$ 3000 | |
| Cells Expressing Glypican 3 (Heparan Sulphate Proteoglycan or Intestinal Protein OCI 5 or GTR2 2 or MXR7 or GPC3) - Drugs in Development, 2021
Cells Expressing Glypican 3 (Heparan Sulphate Proteoglycan or Intestinal Protein OCI 5 or GTR2 2 or MXR7 or GPC3) - Drugs in Development, 2021 Summar...
Published: Apr-2021 | No. of Pages: 80
|
$ 3000 | |
| Serine/Threonine Protein Kinase DCLK1 (Doublecortin Domain Containing Protein 3A or Doublecortin Like And CAM Kinase Like 1 or Doublecortin Like Kinase 1 or DCLK1 or EC 2.7.11.1) - Drugs in Development, 2021
Serine/Threonine Protein Kinase DCLK1 (Doublecortin Domain Containing Protein 3A or Doublecortin Like And CAM Kinase Like 1 or Doublecortin Like Kinas...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Marginal Zone B-cell Lymphoma (Oncology) - Drugs in Development, 2021
Marginal Zone B-cell Lymphoma (Oncology) - Drugs in Development, 2021 Summary Marginal Zone B-cell Lymphoma (Oncology) - Drugs in Development, 2021 ...
Published: Apr-2021 | No. of Pages: 200
|
$ 2500 | |
| Urinary Tract Infections Due To Catheter Encrustation (Infectious Disease) - Drugs in Development, 2021
Urinary Tract Infections Due To Catheter Encrustation (Infectious Disease) - Drugs in Development, 2021 Summary Urinary Tract Infections Due To Cath...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Cells Expressing Myeloid Cell Surface Antigen CD33 (Sialic Acid Binding Ig Like Lectin 3 or gp67 or CD33) - Drugs in Development, 2021
Cells Expressing Myeloid Cell Surface Antigen CD33 (Sialic Acid Binding Ig Like Lectin 3 or gp67 or CD33) - Drugs in Development, 2021 Summary Cells...
Published: Apr-2021 | No. of Pages: 90
|
$ 3000 | |
| DNA Topoisomerase IV (EC 5.99.1.3) - Drugs in Development, 2021
DNA Topoisomerase IV (EC 5.99.1.3) - Drugs in Development, 2021 Summary DNA Topoisomerase IV (EC 5.99.1.3) - Drugs in Development, 2021 provides in ...
Published: Apr-2021 | No. of Pages: 80
|
$ 3000 | |
| Serine/Threonine Protein Kinase/Endoribonuclease IRE1 (Endoplasmic Reticulum To Nucleus Signaling 1 or Inositol Requiring Protein 1 or Ire1 Alpha or Endoribonuclease or ERN1 or EC 2.7.11.1 or EC 3.1.26.) - Drugs in Development, 2021
Serine/Threonine Protein Kinase/Endoribonuclease IRE1 (Endoplasmic Reticulum To Nucleus Signaling 1 or Inositol Requiring Protein 1 or Ire1 Alpha or E...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) (Oncology) - Drugs in Development, 2021
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) (Oncology) - Drugs in Development, 2021 Summary B-Cell Acute Lymphocytic Le...
Published: Apr-2021 | No. of Pages: 220
|
$ 2500 |